Ledger.Open graph →
SEC Form D · filed March 16, 2015

OMNI BIO PHARMACEUTICAL, INC

Offering
—
Sold
—
Exemption
Rule 506(b)
Industry
Biotechnology
Location
FORT COLLINS, CO
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (19)

Michael F. Kamarck · Ithaca, NYDirectorAlbert F. Kramer · Swampscott, MADirectorDavid N. Fisher Iii · NEWPORT BEACH, CADirectorCharles F. Dinarello · Boulder, COExecJohn F. Riccardi · Harleysville, PAExecMichael F. Wort · Fort Collins, CODirectorBruce E. Schneider · Malvern, PAExec · DirectorRick F. Seefried · Centennial, COPromoterSandy F. Wrobel · San Mateo, CADirectorJoseph F. Lavigne · Centennial, COPromoterDouglas Knapke · Gahanna, OHDirectorCharles F. Dinarello · Boulder, COExecJohn F. Riccardi · Harleysville, PAExecMichael F. Wort · Fort Collins, CODirectorBruce E. Schneider · Malvern, PAExec · DirectorMichael F. Kamarck · Ithaca, NYDirectorRick F. Seefried · Centennial, COPromoterSandy F. Wrobel · San Mateo, CADirectorJoseph F. Lavigne · Centennial, COPromoter

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗